According to FutureWise analysis the market for pigmentation disorders treatment in 2023 is US$ 6.99 billion, and is expected to reach US$ 12.11 billion by 2031 at a CAGR of 7.10%.
Pigmentation disorders refer to the lightening or darkening of skin color in comparison to normal. Pigmentation is primarily caused by the presence of a chemical substance called melanin, which is responsible for the skin's complexion. Our skin is protected by melanin from sun light that penetrates deep within. The overproduction of melanin in some cases results in a dark complexion, and the underproduction of melanin results in a light complexion. It is not uncommon for pigmentation disorders to be caused by overexposure to the sun, stress, hormonal changes, and other factors. Pigmentation disorders appear as discolored and blotchy patches of skin. Various special cells present in the body produce a skin component called melanin that regulates skin color.
Melanocytes that are damaged or unhealthy result in reduced or excessive melanin production, resulting in pigmentation. Melasma (hyperpigmentary disorder), vitiligo (hypopigmentary disorder), albinism (inherited rare disorder) and post inflammatory hyperpigmentation are the most common pigmentation disorders. Melasma is caused by hormonal changes such as pregnancy and oral contraceptives; as well as excessive sun exposure on the skin that increases the concentration of melanin. In the pigmentation disorder treatment market, an improved lifestyle is anticipated to be the primary factor driving growth. Growing aging populations, rising incidence rates for skin disorders, a growing number of smokers, global warming, and increasing disposable income are among other factors driving the pigmentation disorder treatment market.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Pigmentation Disorders Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Pigmentation Disorders Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.